Back to search

Netherlands· NL-c81a3af9cde6

Copalia 10 mg/160 mg, filmomhulde tabletten

A valsartan and amlodipine product containing amlodipinebesilaat + valsartan, registered in Netherlands by Novartis Europharm Limited. The same ATC class is registered in 14 of our 19 countries.

ATC C09DB01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedCopalia 10 mg/160 mg, filmomhulde tab…ATCC09DB01REGISTER NO.NL-c81a3af9cde6PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Valsartan and amlodipine is registered in 14 of 19 countries.

Countries holding a registration under ATC C09DB01 (valsartan and amlodipine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 10 of them publish a price we can compare per daily dose

Valsartan and amlodipine · ATC C09DB01

14 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
AMLODIPINEBESILAAT + VALSARTAN
Manufacturer
Novartis Europharm Limited
Country
Netherlands (NL)
ATC code
C09DB01
ATC class
Valsartan and amlodipine
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/06/372

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

81 interactions on record for valsartan and amlodipine.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Valsartan and amlodipine · interactions on record

81 records

81 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d7b14fb6-771e-48c5-b5ad-20fd4617a453
GET /v1/drugs/d7b14fb6-771e-48c5-b5ad-20fd4617a453?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/copalia-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Valsartan And Amlodipine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp73395",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSPOVIDON (E 1202)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ROOD  (E 172)",
    "MACROGOL 4000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "SILICIUMDIOXIDE (E 551)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "AMLODIPINEBESILAAT",
    "VALSARTAN"
  ],
  "leaflet_url": null,
  "authorised_at": "2007/01/16",
  "procedure_number": "EMEA/H/C/000774",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/06/372",
  "additional_monitoring": "N"
}

See everything about valsartan and amlodipine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.